Literature DB >> 23250473

[CGM-continuous glucose monitoring - statement of the Austrian Diabetes Association].

Ingrid Schütz-Fuhrmann1, Edith Schober, Birgit Rami, Marietta Stadler, Martin Bischof, Sandra Fortunat, Markus Laimer, Raimund Weitgasser, Rudolf Prager.   

Abstract

This position statement represents the recommendations of the Austrian Diabetes Association regarding the clinical diagnostic and therapeutic application, safety and benefits of continuous subcutaneous glucose monitoring systems in patients with diabetes mellitus, based on current evidence.

Entities:  

Mesh：

Year:  2012        PMID： 23250473     DOI： 10.1007/s00508-012-0291-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  7 in total

1.  Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Authors:  Dorothee Deiss; Jan Bolinder; Jean-Pierre Riveline; Tadej Battelino; Emanuele Bosi; Nadia Tubiana-Rufi; David Kerr; Moshe Phillip
Journal:  Diabetes Care       Date:  2006-12       Impact factor: 19.112

2.  Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Authors:  Richard M Bergenstal; William V Tamborlane; Andrew Ahmann; John B Buse; George Dailey; Stephen N Davis; Carol Joyce; Tim Peoples; Bruce A Perkins; John B Welsh; Steven M Willi; Michael A Wood
Journal:  N Engl J Med       Date:  2010-06-29       Impact factor: 91.245

3.  Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.

Authors:  O Kordonouri; E Pankowska; B Rami; T Kapellen; R Coutant; R Hartmann; K Lange; M Knip; T Danne
Journal:  Diabetologia       Date:  2010-08-14       Impact factor: 10.122

4.  Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors:  William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  N Engl J Med       Date:  2008-09-08       Impact factor: 91.245

5.  The effect of continuous glucose monitoring in well-controlled type 1 diabetes.

Authors:  Roy W Beck; Irl B Hirsch; Lori Laffel; William V Tamborlane; Bruce W Bode; Bruce Buckingham; Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart A Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal:  Diabetes Care       Date:  2009-05-08       Impact factor: 19.112

6.  Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.

Authors:  Denis Raccah; Véronique Sulmont; Yves Reznik; Bruno Guerci; Eric Renard; Hélène Hanaire; Nathalie Jeandidier; Marc Nicolino
Journal:  Diabetes Care       Date:  2009-09-18       Impact factor: 19.112

7.  Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.

Authors:  Helen R Murphy; Gerry Rayman; Karen Lewis; Susan Kelly; Balroop Johal; Katherine Duffield; Duncan Fowler; Peter J Campbell; Rosemary C Temple
Journal:  BMJ       Date:  2008-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.